Sodium Polystyrene Sulfonate 4.1 meq/g

Sodium Polystyrene Sulfonate 4.1 meq/g is a medication used to reduce high potassium levels in the blood. This powder, for suspension, is administered orally or rectally and is available in a 454 g jar.

Sodium Polystyrene Sulfonate is primarily used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood. This medication works by binding to potassium in the gastrointestinal tract, facilitating its removal from the body. It is often prescribed for patients with kidney issues or those undergoing dialysis. The powder form allows for flexible administration, either orally or rectally, depending on the patient's needs.

Common effects of Sodium Polystyrene Sulfonate may include gastrointestinal discomfort, such as nausea, vomiting, or constipation. Some users might experience changes in bowel movements or sorbitol-related side effects if the medication is mixed with sorbitol. It is important to follow the prescribed administration method to minimize these effects.

Sodium Polystyrene Sulfonate should be used with caution in patients with severe constipation or bowel obstruction. It is essential to stay hydrated and monitor potassium levels regularly while using this medication. Always consult a healthcare provider before starting or adjusting the dosage of Sodium Polystyrene Sulfonate.

Sodium Polystyrene Sulfonate may interact with other medications, particularly those taken orally, as it can bind to them and reduce their effectiveness. It is advisable to space out the administration of other medications by at least 3 hours. Additionally, the use of sorbitol with this medication can increase the risk of side effects, so it should be used cautiously.